Both in Pharmaceuticals
Actinium Pharmaceuticals vs Serina Therapeutics
Over the past year ATNM returned +4.3% and SER returned −62.6%; their daily moves had a correlation of 0.10.
ATNM +4.3% SER −62.6%Growth of $1, one year, split-adjusted
| Metric | ATNM | SER |
|---|---|---|
| Price | $1.43 | $1.85 |
| Market cap | $45.0M | $47.0M |
| Today | −3.38% | −4.64% |
| 1 month | +22.2% | −5.6% |
| 6 months | +19.2% | −2.6% |
| Year to date | +5.1% | −3.3% |
| 1 year | +0.7% | −61.4% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | 100.0% | — |
| Net margin | 79.7% | — |
| P/E (TTM) | 4.0× | — |
| Price / sales | 1.3× | — |
| Net cash | $36.5M | $19.9M |
| Dividend yield | — | — |
| Volatility (60d) | 90.8% | 78.4% |
| Short % of float | 2.0% | 0.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).